Professional Documents
Culture Documents
Non-Invasive Blood Gulcometer
Non-Invasive Blood Gulcometer
AG:
Non-invasive
Blood Glucometer
Presented by Group 5 :
The global distribution and future estimates of diabetes patients
(2019, 2030, 2045)
Non-invasive Detection
Income Statement-Year 5
(Million USD)
Revenue $4,500
Cardeal, N. & António, N. 2012, ‘Valuable, rare, inimitable resources and organization (VRIO) resources or valuable,
rare, inimitable resources (VRI) capabilities: What leads to competitive advantage?’, South African Journal of
Business Management, vol.6, no.37, DOI:10.5897/AJBM12.295.
International Diabetes Federation 2019, The global impact of diabetes, accessed 18 October 2020, <https://idf.org>.
Nasiri, N. & Clarke, C. 2019, ‘Nano-structured Chemiresistive Gas Sensors for Medical Applications’,
Multidisciplinary Digital Publishing Institute, vol.19, no.3, DOI: 10.3390/s19030462.
Roche Holdings, Inc., 2019, Financial Report 2019, accessed 21 October 2020,
<https://www.roche.com/dam/jcr:cb961563-33e7-4949-a426-bd6eb020c785/en/RHI_Annual_Report_2019.pdf>.
Roche Holdings, Inc., 2020, YTD September 2020 sales, accessed 20 October 2020,
<https://www.roche.com/dam/jcr:8c017df4-4f19-4b84-ad1a-ac0328a30d4f/en/irp201015-a.pdf>.
Vashist, S.K. 2012, ‘Non-invasive glucose monitoring technology in diabetes management: A review’, Analytica
Chimica Acta, vol.750, pp.16-27, DOI:https://doi.org/10.1016/j.aca.2012.03.043.